On a reported basis in the quarter, earnings per share was $9.03 as compared to $7.84 in the prior year.
On a reported basis in the quarter, earnings per share was $9.03 as compared to $7.84 in the prior year.
Adjusted earnings per share for the quarter was $9.26, a 19% increase over the prior year amount of $7.78.
Laboratory sales increased 5%, industrial declined 1% with core industrial up 2%, and Product Inspection down 7%.
For the full year 2021, we now expect local currency sales growth will be in the range of 5% to 7% as compared to 2020.
We expect full year adjusted earnings per share will be in the range of $29.20 to $29.80, which is a growth rate of 14% to 16%.
